West Pharmaceutical Services (WST) Gross Margin (2016 - 2025)
Historic Gross Margin for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to 36.58%.
- West Pharmaceutical Services' Gross Margin rose 11400.0% to 36.58% in Q3 2025 from the same period last year, while for Sep 2025 it was 35.58%, marking a year-over-year increase of 7000.0%. This contributed to the annual value of 34.51% for FY2024, which is 37700.0% down from last year.
- West Pharmaceutical Services' Gross Margin amounted to 36.58% in Q3 2025, which was up 11400.0% from 35.73% recorded in Q2 2025.
- West Pharmaceutical Services' Gross Margin's 5-year high stood at 43.55% during Q2 2021, with a 5-year trough of 32.76% in Q2 2024.
- Its 5-year average for Gross Margin is 37.88%, with a median of 38.01% in 2023.
- As far as peak fluctuations go, West Pharmaceutical Services' Gross Margin soared by 65600bps in 2021, and later crashed by -59000bps in 2024.
- West Pharmaceutical Services' Gross Margin (Quarter) stood at 41.13% in 2021, then fell by -10bps to 36.98% in 2022, then rose by 3bps to 38.01% in 2023, then dropped by -4bps to 36.54% in 2024, then rose by 0bps to 36.58% in 2025.
- Its Gross Margin was 36.58% in Q3 2025, compared to 35.73% in Q2 2025 and 33.22% in Q1 2025.